S. Nobusawa

Genetics · 2009

A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom S. Nobusawa trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. H. Ohgaki
  2. Takuya Watanabe
  3. P. Kleihues

Who trusts S. Nobusawa overall

  1. H. Ohgaki
  2. McKinsey L. Goodenberger
  3. P. Kleihues

Papers from S. Nobusawa's perspective

Ordered by how strongly the researchers S. Nobusawa trusts endorse each paper. Same corpus, a different order for every researcher.

  1. An Integrated Genomic Analysis of Human Glioblastoma Multiforme (Science)
  2. IDH1 and IDH2 mutations in gliomas. (New England Journal of Medicine)
  3. Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α (Science)
  4. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. (American Journal of Pathology)
  5. Analysis of the IDH1 codon 132 mutation in brain tumors (Acta Neuropathologica)
  6. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. (Cancer Cell)
  7. Prediction of central nervous system embryonal tumour outcome based on gene expression (Nature)
  8. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. (Cancer Cell)
  9. IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas (Neuro-Oncology)
  10. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzymatic activity that converts α-ketoglutarate to 2-hydroxyglutarate (Cancer Cell)

Their papers